{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:05:13Z","timestamp":1790136313087,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1770-1","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T09:24:48Z","timestamp":1471512288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6192-1653","authenticated-orcid":false,"given":"Takahiko","family":"Fukuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goh","family":"Ohji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,18]]},"reference":[{"key":"1770_CR1","first-page":"165","volume":"62","author":"V Signs","year":"2013","unstructured":"Signs V. Carbapenem-Reistant Enterobacteriaceae. MMWR. 2013;62:165\u201370.","journal-title":"MMWR"},{"issue":"12","key":"1770_CR2","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","volume":"67","author":"KZ Vardakas","year":"2012","unstructured":"Vardakas KZ, Tansarli GS, Rafailidis PI, Falagas ME. Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum beta-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother. 2012;67(12):2793\u2013803.","journal-title":"J Antimicrob Chemother"},{"key":"1770_CR3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/502018","volume":"23","author":"Force TBART","year":"2002","unstructured":"Force TBART. The Cost of Antibiotic Resistance: Effect of Resistance Among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa on Length of Hospital Stay. Infection Control and Hospital Epideimology. 2002;23:106\u20138.","journal-title":"Infection Control and Hospital Epideimology"},{"issue":"5","key":"1770_CR4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkm318","volume":"60","author":"MJ Schwaber","year":"2007","unstructured":"Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother. 2007;60(5):913\u201320.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"1770_CR5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s15010-014-0670-9","volume":"42","author":"R Leistner","year":"2014","unstructured":"Leistner R, Gurntke S, Sakellariou C, Denkel LA, Bloch A, Gastmeier P, et al. Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort. Infection. 2014;42(6):991\u20137.","journal-title":"Infection"},{"key":"1770_CR6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/420816","volume":"39","author":"D Paterson","year":"2003","unstructured":"Paterson D. Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum B-Lactamase. Clin Infect Dis. 2003;39:31\u20137.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"1770_CR7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/666642","volume":"33","author":"D Marchaim","year":"2012","unstructured":"Marchaim D, Chopra T, Bhargava A, Bogan C, Dhar S, Hayakawa K, et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship. Infect Control Hosp Epidemiol. 2012;33(8):817\u201330.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"1770_CR8","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1128\/AAC.00143-10","volume":"54","author":"M Tumbarello","year":"2010","unstructured":"Tumbarello M, Spanu T, Di Bidino R, Marchetti M, Ruggeri M, Trecarichi EM, et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother. 2010;54(10):4085\u201391.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1770_CR9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jhin.2009.02.021","volume":"73","author":"ME Falagas","year":"2009","unstructured":"Falagas ME, Karageorgopoulos DE. Extended-spectrum beta-lactamase-producing organisms. J Hosp Infect. 2009;73(4):345\u201354.","journal-title":"J Hosp Infect"},{"issue":"4","key":"1770_CR10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"DL Paterson","year":"2005","unstructured":"Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657\u201386.","journal-title":"Clin Microbiol Rev"},{"key":"1770_CR11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/clinids\/10.4.867","volume":"10","author":"V Jarlier","year":"1988","unstructured":"Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum \u03b2-lactamases conferring transferable resistance to newer \u03b2-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988;10:867\u201378.","journal-title":"Rev Infect Dis"},{"key":"1770_CR12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ccc.2009.08.004","volume":"25","author":"A Kumar","year":"2009","unstructured":"Kumar A. Optimizing antimicrobial therapy in sepsis and septic shock. Crit Care Clin. 2009;25:733\u201351.","journal-title":"Crit Care Clin"},{"issue":"9","key":"1770_CR13","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1128\/AAC.00701-15","volume":"59","author":"Y Matsumura","year":"2015","unstructured":"Matsumura Y, Yamamoto M, Nagao M, Komori T, Fujita N, Hayashi A, et al. Multicenter Retrospective Study of Cefmetazole and Flomoxef for Treatment of Extended-Spectrum-beta-Lactamase-Producing Escherichia coli Bacteremia. Antimicrob Agents Chemother. 2015;59(9):5107\u201313.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1770_CR14","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.ijid.2012.09.010","volume":"17","author":"A Doi","year":"2013","unstructured":"Doi A, Shimada T, Harada S, Iwata K, Kamiya T. The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae. Int J Infect Dis. 2013;17(3):e159\u201363.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"1770_CR15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.diagmicrobio.2014.07.006","volume":"80","author":"HY Tsai","year":"2014","unstructured":"Tsai HY, Chen YH, Tang HJ, Huang CC, Liao CH, Chu FY, et al. Carbapenems and piperacillin\/tazobactam for the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Proteus mirabilis. Diagn Microbiol Infect Dis. 2014;80(3):222\u20136.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"1770_CR16","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/cid\/civ003","volume":"60","author":"PD Tamma","year":"2015","unstructured":"Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, et al. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum beta-lactamase bacteremia. Clin Infect Dis. 2015;60(9):1319\u201325.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1770_CR17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1345\/aph.1Q473","volume":"46","author":"JJ Fong","year":"2012","unstructured":"Fong JJ, Ros\u00e9 L, Radigan EA. Clinical outcomes with ertapenem as a first-line treatment option of infections caused by extended-spectrum \u03b2-lactamase producing gram-negative bacteria. Ann Pharmacother. 2012;46(3):347\u201352.","journal-title":"Ann Pharmacother"},{"key":"1770_CR18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/1471-2334-13-523","volume":"13","author":"C Lim","year":"2013","unstructured":"Lim C. Evaluation of Ertapenem use with Impact Assessment on Extended-Spectrum Beta-Lactamase (ESBL) Production and Gram-Negative resistance in Singapore General Hospital (SGH). BMC Infectious Disease. 2013;13:523.","journal-title":"BMC Infectious Disease"},{"issue":"7","key":"1770_CR19","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3346\/jkms.2013.28.7.998","volume":"28","author":"CI Kang","year":"2013","unstructured":"Kang CI, Cha MK, Kim SH, Ko KS, Wi YM, Chung DR, et al. Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli over a 6-year period. J Korean Med Sci. 2013;28(7):998\u20131004.","journal-title":"J Korean Med Sci"},{"issue":"10","key":"1770_CR20","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1093\/jac\/dku215","volume":"69","author":"SH Park","year":"2014","unstructured":"Park SH, Choi SM, Chang YK, Lee DG, Cho SY, Lee HJ, et al. The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum beta-lactamase-producing Escherichia coli. J Antimicrob Chemother. 2014;69(10):2848\u201356.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"1770_CR21","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/AAC.05753-11","volume":"56","author":"HC Chung","year":"2012","unstructured":"Chung HC, Lai CH, Lin JN, Huang CK, Liang SH, Chen WF, et al. Bacteremia caused by extended-spectrum-beta-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob Agents Chemother. 2012;56(2):618\u201322.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1770-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T15:13:48Z","timestamp":1749050028000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1770-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,18]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1770"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1770-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,18]]},"article-number":"427"}}